Patients with MGMT methylated glioblastoma also had a longer overall survival with ≥30% NCE tumor resection (425 days; 95% CI, 286–564) than with <30% NCE tumor resection (190 days; 95% CI, 107–273; p = 0.001) (Figure 1B). Here, MGMT is linked to glioblastoma.